Malta vs United Kingdom of Great Britain and Northern Ireland: Hepatitis B surface antigen (HBsAg) prevalence
Malta
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
Malta rank
132nd
United Kingdom of Great Britain and Northern Ireland rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Malta
- United Kingdom of Great Britain and Northern Ireland
How they compare
Malta currently reports 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
Across all 10 years both countries report, United Kingdom of Great Britain and Northern Ireland has been ahead every year.
Malta ranks 132nd and United Kingdom of Great Britain and Northern Ireland ranks 132nd of 194 countries.
United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | United Kingdom of Great Britain and Northern Ireland |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Malta or United Kingdom of Great Britain and Northern Ireland?
- Malta, at 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Malta and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and United Kingdom of Great Britain and Northern Ireland?
- 10 years are reported by both, from 2015 to 2024.
- How do Malta and United Kingdom of Great Britain and Northern Ireland rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Malta ranks 132nd and United Kingdom of Great Britain and Northern Ireland ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.